Objective. To treat neurological and psychiatric diseases with deep brain stimulation (DBS),
a trained clinician must select parameters for each patient by monitoring their symptoms and …

Neural-electronic interfaces through delivering electroceuticals to lesions and modulating
pathological endogenous electrical environments offer exciting opportunities to treat drug …

Brain-computer interfaces (BCIs) offer an implicit, non-linguistic communication channel
between users and machines. Despite their potential, BCIs are far from becoming a …

Objective. Therapeutic brain stimulation is conventionally delivered using constant-
frequency stimulation pulses. Several recent clinical studies have explored how …

Introduction As highlighted by the scientific literature, music therapy (MT) represents a
significant non-pharmacological intervention within neurorehabilitation programs. MT offers …

Feature encouraging evidence of neuroprotection, with none of the serious side effects, such
as brain swelling or bleeding, that often accompany the antibody drugs currently available or …

Alzheimers disease (AD) presents a critical global health challenge, with current therapies
offering limited efficacy and safety in halting disease progression. Gamma sensory …

Gamma oscillations are disrupted in various neurological disorders, including Alzheimer's
disease (AD). In AD mouse models, non-invasive audiovisual stimulation (AuViS) at 40 Hz …

40 Hz sensory stimulation (“flicker”) has emerged as a new technique to potentially mitigate
pathology and improve cognition in mouse models of Alzheimer's disease (AD) pathology …

Visual gamma entrainment using sensory stimuli (vGENUS) is a promising non-invasive
therapeutic approach for Alzheimer's disease (AD), showing efficacy in improving memory …